Should a patient with Down syndrome who underwent hip replacement and has been on a fentanyl transdermal patch since surgery have the patch discontinued?

Yes, the fentanyl patch should be discontinued in this patient with Down syndrome following hip replacement surgery.

The fentanyl transdermal patch is contraindicated for acute postoperative pain management and should be removed. This patient is now in the post-surgical recovery phase where pain requirements are expected to decrease, making the long-acting fentanyl patch particularly dangerous 1, 2.

Key Clinical Reasoning

Why the Patch Must Be Stopped

Fentanyl patches are explicitly NOT recommended for postoperative pain because:

• Pain decreases more rapidly after surgery than fentanyl blood levels can be adjusted, creating risk of life-threatening respiratory depression 2
• The patch has a 17-48 hour delay to reach therapeutic levels and takes 20-27 hours for serum levels to fall by 50% after removal 3, 4
• This pharmacokinetic profile makes dose adjustment impossible in the dynamic postoperative period 1

Special Vulnerability in This Patient

The inability to assess pain in this patient with Down syndrome creates additional safety concerns:

• You cannot titrate to effect when the patient cannot communicate pain levels
• Respiratory depression may go unrecognized longer
• Opioid-related adverse effects (sedation, confusion, respiratory compromise) cannot be reported by the patient

Long-Acting Opioids Are Contraindicated Postoperatively

Long-acting opioids including transdermal patches are one of the three major modifiable risk factors for persistent postoperative opioid use and show no benefit in postoperative pain management 5. Multiple guidelines explicitly state that modified-release opioid preparations (including transdermal patches) should be avoided without specialist consultation after surgery 6.

Safe Discontinuation Protocol

Immediate Actions

1. Remove the patch immediately - fold adhesive sides together and flush down toilet 3
2. Monitor closely for 72-96 hours after removal due to continued fentanyl absorption from skin depot 3
3. Examine skin to ensure all patches removed (accidental multiple patches can occur) 3

Transition Strategy

Do NOT abruptly stop without a plan - the patient is likely physically dependent after prolonged use 3:

• Convert to immediate-release oral morphine as the preferred opioid 7
• Calculate equianalgesic dose from the fentanyl patch strength (use conversion tables) [@1-10@]
• Reduce by 25-50% to account for incomplete cross-tolerance 8
• Provide scheduled doses every 3-4 hours initially, not PRN only

Specific Dosing Approach

For a patient on fentanyl 25 mcg/h patch:

• This equals approximately 60 mg oral morphine per day 8
• Reduce by 50% = 30 mg oral morphine daily
• Divide into 6 doses = 5 mg oral morphine every 4 hours
• Use liquid morphine 10 mg/5 mL for easier titration in patients who cannot communicate 6

Monitoring Parameters

Since this patient cannot report pain:

• Use functional outcomes rather than pain scores 5
• Assess: ability to participate in physical therapy, sleep quality, agitation/distress behaviors
• Monitor respiratory rate, sedation level, bowel function
• Watch for withdrawal signs: restlessness, tachycardia, hypertension, mydriasis 3

Common Pitfalls to Avoid

1. Do not leave the patch on thinking "the patient is stable" - stability now doesn't predict tomorrow's needs as surgical pain resolves
2. Do not abruptly discontinue without transitioning to short-acting opioids - this causes severe withdrawal 3
3. Do not use another long-acting formulation - only immediate-release opioids allow appropriate titration 5, 6
4. Do not rely on PRN dosing alone - establish a scheduled taper with breakthrough doses available
5. Do not assume patch removal means immediate effect - fentanyl continues absorbing for 20+ hours 3

Ongoing Management

• Wean opioids first in the reverse analgesic ladder, before stopping NSAIDs or acetaminophen 6
• Decrease morphine dose by no more than 25% every 2-4 weeks to avoid withdrawal 3
• Engage physical therapy and multimodal analgesia (acetaminophen, NSAIDs if not contraindicated)
• Plan for complete opioid cessation within 5-7 days post-discharge for most orthopedic procedures 6
• Ensure caregivers understand the taper plan and disposal of unused medications 6, 3

The combination of postoperative status, inability to assess pain, and the inherent dangers of long-acting opioids in this setting makes patch discontinuation medically necessary, not optional.